150 related articles for article (PubMed ID: 23919878)
1. A large primary vaginal leiomyosarcoma diagnosed postoperatively and uterine leiomyomas treated with surgery and chemotherapy.
Tsai HJ; Ruan CW; Kok VC; Li MC
J Obstet Gynaecol; 2013 Aug; 33(6):643-4. PubMed ID: 23919878
[No Abstract] [Full Text] [Related]
2. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
Hensley ML; Ishill N; Soslow R; Larkin J; Abu-Rustum N; Sabbatini P; Konner J; Tew W; Spriggs D; Aghajanian CA
Gynecol Oncol; 2009 Mar; 112(3):563-7. PubMed ID: 19135708
[TBL] [Abstract][Full Text] [Related]
3. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
Ricci S; Giuntoli RL; Eisenhauer E; Lopez MA; Krill L; Tanner EJ; Gehrig PA; Havrilesky LJ; Secord AA; Levinson K; Frasure H; Celano P; Fader AN
Gynecol Oncol; 2013 Dec; 131(3):629-33. PubMed ID: 24016408
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes.
Littell RD; Tucker LY; Raine-Bennett T; Palen TE; Zaritsky E; Neugebauer R; Embry-Schubert J; Lentz SE
Gynecol Oncol; 2017 Oct; 147(1):11-17. PubMed ID: 28747255
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.
Takano T; Niikura H; Ito K; Nagase S; Utsunomiya H; Otsuki T; Toyoshima M; Tokunaga H; Kaiho-Sakuma M; Shiga N; Nagai T; Tanaka S; Otsuki A; Kurosawa H; Shigeta S; Tsuji K; Yamaguchi T; Yaegashi N
Int J Clin Oncol; 2014 Oct; 19(5):897-905. PubMed ID: 24149774
[TBL] [Abstract][Full Text] [Related]
6. Cardiac metastasis from uterine leiomyosarcoma.
Moreno Antón F; Casado Herraez A; Puente Vázquez J; Gómez Díaz R; Aragoncillo P; Díaz-Rubio García E
Clin Transl Oncol; 2006 May; 8(5):375-8. PubMed ID: 16760015
[TBL] [Abstract][Full Text] [Related]
7. Leiomyosarcoma of the vagina.
Miyakawa I; Yasuda H; Taniyama K; Mori N; Uehara Y; Sumiyoshi A
Int J Gynaecol Obstet; 1985 Jun; 23(3):213-6. PubMed ID: 2865184
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma: a rare malignant change in a leiomyoma.
Jatoi N
J Coll Physicians Surg Pak; 2003 Feb; 13(2):106-7. PubMed ID: 12685956
[TBL] [Abstract][Full Text] [Related]
9. [Leiomyosarcoma and leiomyoma of the vagina].
Horn LC; Fischer U; Reuter S; Pyttel C
Zentralbl Gynakol; 1998; 120(1):38-41. PubMed ID: 9499550
[TBL] [Abstract][Full Text] [Related]
10. Recurrent vaginal epithelioid leiomyosarcoma; a case report from Botswana and review of the literature.
Benti TM; Mercy N; Eshetu AB; Iwuh IE; Kassa MW
Afr J Reprod Health; 2021 Feb; 25(1):161-168. PubMed ID: 34077121
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
Hensley ML; Maki R; Venkatraman E; Geller G; Lovegren M; Aghajanian C; Sabbatini P; Tong W; Barakat R; Spriggs DR
J Clin Oncol; 2002 Jun; 20(12):2824-31. PubMed ID: 12065559
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine/docetaxel--welcome to a new standard.
Fleming G
Gynecol Oncol; 2008 Jun; 109(3):313-5. PubMed ID: 18534248
[No Abstract] [Full Text] [Related]
13. Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.
Hensley ML; Miller A; O'Malley DM; Mannel RS; Behbakht K; Bakkum-Gamez JN; Michael H
J Clin Oncol; 2015 Apr; 33(10):1180-5. PubMed ID: 25713428
[TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
Ricci S; Stone RL; Fader AN
Gynecol Oncol; 2017 Apr; 145(1):208-216. PubMed ID: 28209496
[TBL] [Abstract][Full Text] [Related]
15. Leiomyomas of the uterus, ovary and vaginal wall. A case report.
Hashimoto S; Taga M; Endoh M; Ikeda M; Shirasu K; Uemura T; Hara M; Minaguchi H
Gynecol Obstet Invest; 1997; 44(4):275-7. PubMed ID: 9415528
[No Abstract] [Full Text] [Related]
16. A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.
Shan W; Akinfenwa PY; Savannah KB; Kolomeyevskaya N; Laucirica R; Thomas DG; Odunsi K; Creighton CJ; Lev DC; Anderson ML
Clin Cancer Res; 2012 Jun; 18(12):3352-65. PubMed ID: 22535157
[TBL] [Abstract][Full Text] [Related]
17. Vaginal leiomyoma co-existing with broad ligament and multiple uterine leiomyomas.
Meniru GI; Wasdahl D; Onuora CO; Hecht BR; Hopkins MP
Arch Gynecol Obstet; 2001 May; 265(2):105-7. PubMed ID: 11409472
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH
Cancer; 2013 Apr; 119(8):1555-61. PubMed ID: 23335221
[TBL] [Abstract][Full Text] [Related]
19. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.
Takehara K; Yamashita N; Watanabe R; Teramoto N; Tsuda H; Motohashi T; Harano K; Nakanishi T; Tokunaga H; Susumu N; Ueda Y; Yokoyama Y; Saito T
Gynecol Oncol; 2020 Apr; 157(1):115-120. PubMed ID: 31983515
[TBL] [Abstract][Full Text] [Related]
20. Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma.
Kadhel P; Smail M; Borja De Mozota D
J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):609-611. PubMed ID: 28647614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
